2017 ASCO Annual Meeting

Pedram Razavi, MD, PhD, Memorial Sloan-Kettering Cancer Center, presenting Abstract LBA11516, Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer, during Saturday Press Briefing

Chicago, IL - 2017 ASCO Annual Meeting - Pedram Razavi, MD, PhD, Memorial Sloan-Kettering Cancer Center, presenting Abstract LBA11516, Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer, during Saturday Press Briefing at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Saturday, June 3, 2017. Approximately 40,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 53rd Annual Meeting, which is being held at McCormick Place. The ASCO Annual Meeting highlights the latest findings in all major areas of oncology, from basic to clinical and epidemiological studies. Photo by © ASCO/Brian Powers 2017 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org